Abstract

Nanomedicine is the medical application of nanotechnology for the treatment and prevention of major ailments, including cancer and cardiovascular diseases. Despite the progress and potential of nanomedicines, many such materials fail to reach clinical trials due to critical challenges that include poor reproducibility in high-volume production that have led to failure in animal studies and clinical trials. Recent approaches using microfluidic technology have provided emerging platforms with great potential to accelerate the clinical translation of nanomedicine. Microfluidic technologies for nanomedicine development are reviewed in this chapter, together with a detailed discussion of microfluidic assembly, characterization and evaluation of nanomedicine, and a description of current challenges and future prospects. Keywords: microfluidics; nanotechnology; nanomedicine; biomimetic microsystem; clinical translation

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.